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Abstract
Proteins can move from blood circulation into salivary glands through active transportation, passive diffusion or
ultrafiltration, some of which are then released into saliva and hence can potentially serve as biomarkers for diseases
if accurately identified. We present a novel computational method for predicting salivary proteins that come from
circulation. The basis for the prediction is a set of physiochemical and sequence features we found to be discerning
between human proteins known to be movable from circulation to saliva and proteins deemed to be not in saliva. A
classifier was trained based on these features using a support-vector machine to predict protein secretion into saliva.
The classifier achieved 88.56% average recall and 90.76% average precision in 10-fold cross-validation on the
training data, indicating that the selected features are informative. Considering the possibility that our negative
training data may not be highly reliable (i.e., proteins predicted to be not in saliva), we have also trained a ranking
method, aiming to rank the known salivary proteins from circulation as the highest among the proteins in the general
background, based on the same features. This prediction capability can be used to predict potential biomarker
proteins for specific human diseases when coupled with the information of differentially expressed proteins in
diseased versus healthy control tissues and a prediction capability for blood-secretory proteins. Using such
integrated information, we predicted 31 candidate biomarker proteins in saliva for breast cancer.
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Introduction
Human blood has long been used as an information source
for detection of human diseases such as liver enzymes for
detecting hepatitis, white-blood cell counts for infection
detection and prostate-specific antigen (PSA) for diagnosing
prostate cancer. In comparison, human saliva has not been
used for the same purposes nearly as much. Recent large-
scale proteomic analyses have revealed that human saliva is
also rich in proteins [1], some of which come from the blood
circulation and hence can potentially serve as a general
information pool for disease biomarker identification. This study
is on the development of a computational method for
identification of the distinct features of salivary proteins that
come from circulation and an application of the identified
features to predict proteins that can get into saliva from
circulation.
The earliest work on using salivary proteins as disease
biomarkers of distal organs can be traced back to 1986 when
the Kallikreina salivary biomarkers for detection of breast
cancer and gastrointestinal cancer were published [2]. Since
then, a number of salivary proteins have been found to have
elevated levels in patients of specific cancer types compared to
the healthy population such as PSA for prostate cancer [3], c-
tumor protein erbB-2 and p53 for breast cancer [4]. While a few
salivary proteins have been found to be relevant to specific
diseases, there has not been a general and effective approach
for identifying disease markers in saliva, to the best of our
knowledge.
The current understanding about how biomolecules can
move from circulation into saliva can be summarized as
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follows. Three mechanisms have been identified for
biomolecules to travel from circulation into saliva [5,6]: active
transportation for various proteins such as secretory IgA and
immunoglobulin E, passive transportation for drugs and
steroids, and ultrafiltration for small polar molecules such as
creatinine. The basis of our prediction method is that some of
the disease-associated proteins in circulation can get into
saliva through one of these three mechanisms, hence making it
possible for us to identify them in saliva even for diseases of
distal organs.
Two large datasets for salivary proteins are publicly
available. One consists of 1,166 proteins and 657 of them are
also found in human blood [1]. Another one has approximately
2,000 proteins and 26% of them are also found in blood [6]. We
hypothesize that salivary proteins are secreted by the salivary
glands either from circulation or in response to the
biomolecules that get into the glands from circulation. In this
study, we focus on proteins that come from the circulation and
leave the prediction work of proteins secreted by salivary
glands in response to blood proteins that get into the glands as
a future study.
We have collected 62 human salivary proteins coming from
circulation from the published literature, which have been
experimentally detected by multiple salivary proteomic studies,
and used them as the initial positive training data. We then
expanded this dataset by including additional proteins based
on Pfam family information [7]. A total of 261 proteins are
selected at the end as the positive training data. We then
identified a set of proteins that are deemed not to be able to get
into saliva, totaling 6,816, and used them as the negative
training data. We then examined a number of sequence and
structure-based features to identify those with discerning power
between the two sets of proteins. Using these features, we
have trained a classifier using a support vector machine (SVM)
to predict proteins that can travel to saliva from circulation via
salivary glands. In addition, we have also trained a ranking
method aiming to rank the known blood-originated salivary
proteins the highest among the background proteins, knowing
that our negative training data may not be the most reliable.
The flowchart of the approach is shown in Figure 1.
We believe that this prediction capability can serve as a
general tool for predicting proteins that can travel from
circulation to saliva. Hence when applied in conjunction with
capabilities for predicting proteins that may be present in
circulation of patients of a specific disease, this capability can
suggest candidate biomarkers in saliva for that disease. Using
this tool along with gene-expression data of breast cancers and
a prediction tool for blood-secretory proteins [8], we predicted
31 candidate proteins in breast cancer patients’ saliva.
Figure 1.  A flowchart of the approach.  
doi: 10.1371/journal.pone.0080211.g001
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Results
Features of blood-originated salivary proteins
With the aim of training a SVM-based classifier and rank the
predicted proteins, we have examined a total of 34 protein
features (see Table S1 and Material and Methods),
represented as a feature vector of 1,523 dimension. We then
trained a classifier with a linear kernel using these features
calculated on proteins in both the positive and negative training
sets, aiming to derive a classifier that can best distinguish the
positive from the negative samples. We then checked which
feature elements are relevant to the final classification
performance by using a feature selection procedure, and
removed all the irrelevant ones, giving rise to 55 final feature
elements. Then a manifold ranking method [8] is trained based
on the selected feature elements with the performance given in
Table S2. We have assessed the contributions by the 55
feature elements to the classification accuracy, using a
statistical significance q-value [9], and found that the q-values
for the 55 feature elements are less than 4.0E-5, as shown in
Figure 2(A). We have also compared the classification
performance based on the 55 features versus the top 10
features, and noted that there is a clear difference in
performance, as shown in Figure 2(B). The following features
are the most important ones to our classification accuracy,
ranked in the decreasing order of their contribution to the
classification results: radius, Moran autocorrelation,
hydrophobicity, Geary autocorrelation, amino acid composition,
normalized Moreau-Broto autocorrelation, dipeptide
composition, secondary structure composition and polarity.
This observation is consistent with our general understanding
of secretory proteins and salivary proteins. For example, the
diffusion coefficient is inversely proportional to the molecular
radius [10].
Performance of the SVM model
Based on the 55 selected feature elements, we trained a
classifier and evaluated the performance using 10-fold cross
validation by repeating the prediction 100 times to derive a
performance distribution of the classifier. On the training data,
Figure 2.  The q-value and accuracy of the 55 selected features.  
doi: 10.1371/journal.pone.0080211.g002
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the classifier achieved an average recall and precision at
88.56% and 90.76%, respectively. We applied the general
recall-precision curve shown in Figure 3 to the training data
with 10-fold cross validation to examine the prediction precision
at each recall level. The AUC of the recall-precision curve is
80.96%.
We also used 41 of the 62 collected proteins as the training
data that have been reported in the literature before 2000. Out
of the 62 collected proteins, 21 are used as the testing data,
which have been reported after 2000. On these 21 salivary
proteins, our model predicted 14 (76.19%) to be salivary
proteins from blood.
Predicting and ranking the known salivary proteins
We have run the trained classifier on all 20,209 human
proteins in the UniProt database [11], among which 5,456 are
annotated as secretory proteins according to the Uniprot, SPD
[12] and LOCATE [13] databases, and 1,823 have been
detected in saliva from previous experiments [1,5,14]. We
predicted 2,498 of the Uniprot proteins as salivary proteins
from circulation, accounting for 12.36% of the 20,209 Uniprot
proteins. Of the 2,498 proteins, 239 (13.11%) are among the
1,823 proteins that have been previously identified in saliva
experimentally.
We have also ranked the human proteins in UniProt using a
manifold ranking method as done in our previous work [8]. 62
known salivary proteins coming from circulation were assessed
in terms of their ranking to be salivary proteins. By using the 62
proteins as positive dataset, 27 (43.55%) of the 62 proteins and
136 salivary proteins are ranked among the top 1,000 proteins.
By using the expanding 261 proteins as positive dataset, 34
(54.84%) of the 62 proteins are ranked among the top 1,000
proteins. Among these 1,000 proteins, 155 are known to be
salivary proteins identified from other sources (see Table S3 for
the list of the protein names; and also see Material and
Methods). While we do not know if the prediction of the
remaining 845 proteins being salivary proteins is correct or not,
we suspect that some of them are indeed salivary proteins. For
example, protein Endothelin-1 (P05305), ranked the 728th, has
been implicated in cancer[15], and could be a good salivary
biomarker for OSCC development in oral lichen planus patients
[16]. Tissue inhibitor of metalloproteinases 1 (TIMP-1)
(P01033), ranked the 434th, has been identified as a potential
biomarker in diseases such as cancer, cardiovascular diseases
and diabetes. Moreover, this protein has been reported to be a
salivary protein [17].
After the training of our classifier, we did another round of
literature search for additional salivary proteins that have been
associated with human diseases and do not overlap with our
training data. Overall 47 salivary proteins are found, shown in
Table S4. These proteins are relevant to different diseases
such as periodontal disease [18,19], oral squamous cell
Figure 3.  The recall-precision curve.  
doi: 10.1371/journal.pone.0080211.g003
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carcinoma [20,21], Sjögren's syndrome [22-24], breast cancer
[25-29], malignant pelvic tumors, and malignant ovarian tumors
[30]. We found that 3 (6.38%) of these 47 proteins are ranked
among the top 1,000, 8 (17.02%) among the top 2,000 and 12
(25.53%) among the top 3,000, as shown in Table 1. The p-
values for having such rankings if assuming that the ranking is
random are 0.211, 0.088 and 0.038, respectively.
We then carried out a pathway enrichment analysis among
the top 1,000 ranked proteins, using DAVID [31] against the
Gene Ontology, KEGG [32], BBID [33] and BIOCARTA [34]
databases to gain an understanding about the cellular functions
and subcellular locations of these predicted salivary proteins,
using the whole set of human proteins as the background. We
noted that the most significantly enriched biological processes
are immune response, antigen processing and presentation,
cell adhesion, defense response, response to wounding, and
inflammatory response. In addition, the most significantly
enriched cellular components are extracellular region,
membrane and MHC protein complex which all make biological
sense (see Table S5).
Application to breast cancer for identification of
salivary biomarkers
Based on a public transcriptomic dataset collected on breast
cancer and matching control samples (see Materials and
Methods), we identified 1,502 consistently differentially
expressed genes in breast cancer versus control tissue
samples. We then used the gene expression data as an
approximate protein-expression data here; and applied our
trained classifier to these proteins and predicted 248 of them to
Table 1. Comparison of the ranking result with human
saliva biomarkers for many sorts of diseases.
Total protein
number
Known salivary
biomarker
number Top number
Salivary
biomarker
included in top
number P-vlaue
20209 47 500 1 0.367
20209 47 1000 3 0.211
20209 47 1500 6 0.076
20209 47 2000 8 0.088
20209 47 2500 11 0.026
20209 47 3000 12 0.038
20209 47 3500 13 0.052
20209 47 4000 13 0.123
20209 47 4500 15 0.082
20209 47 5000 16 0.098
20209 47 5500 19 0.017
20209 47 6000 20 0.020
doi: 10.1371/journal.pone.0080211.t001
be blood secretory using a prediction tool for blood secretory
proteins that we previously developed [8]. Out of these
proteins, we predicted 31 are movable to saliva. Table 2
provides the detailed information of these 31 proteins as
candidate salivary biomarkers for breast cancer.
As of now, very little data is available regarding salivary
proteins that can be indicative of breast cancer. The only data
we can get hold of is the salivary proteins considered by
Streckfus et al. to be informative for diagnosing breast cancer
[27]. Their predicted list consists of 37 proteins given in Table
S6. We have compared our prediction of 31 proteins with this
list, 4 of the 31 proteins are in their list [27-29], as shown in
Table 3, which has a p-value at 2.89e-7. The relatively low
level of overlap between the two sets of predictions is not
particularly surprising, which is consistent with previously
published studies by different groups on blood biomarkers for
different cancers. This is possibly caused by the differences in
detailed conditions under which the biological samples, i.e.,
cancer tissues and saliva, are collected, as well as the less-
Table 2. Proteins as candidate salivary biomarkers for
breast cancer.
Gene symbol UniProt ID Manifold ranking Fold change
F10 P00742 195 0.667
CFD P00746 227 0.593
TIMP2 P16035 241 0.573
CCL14 Q16627 297 0.595
FBLN1 P23142 324 0.663
FBLN5 Q9UBX5 336 0.542
EFEMP2 O95967 363 0.622
IGF1 P05019 394 0.525
EFEMP1 Q12805 439 0.474
AZGP1 P25311 440 1.563
WISP2 O76076 613 0.581
CLEC3B P05452 720 0.570
CD93 Q9NPY3 724 0.586
LEPR P48357 1034 0.638
FABP5 Q01469 1072 0.633
IL6R P08887 1111 0.551
ALCAM Q13740 1115 1.764
MCAM P43121 1119 0.527
CFB P00751 1148 1.647
PDCD6 O75340 1382 1.562
BCHE P06276 1416 0.665
DMBT1 Q9UGM3 1531 0.632
CD163 Q86VB7 1539 0.628
NCAM1 P13591 1681 0.640
LTF P02788 1693 1.583
SRPX P78539 1959 0.556
FBN1 P35555 2192 0.625
CFH P08603 2400 0.550
VWF P04275 2518 0.537
CD99 P14209 2867 0.623
TF P02787 2907 0.578
doi: 10.1371/journal.pone.0080211.t002
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than-perfect prediction methods employed, on top of the overall
very challenging nature of the problem.
We have also carried out a pathway and subcellular location
enrichment analysis similar to that in the above. We noted that
the most enriched biological processes by these 31 proteins
are response to wounding, acute inflammatory response, cell
adhesion, biological adhesion and immune response, which
are all known to be involved in the development of or in
defense of cancer. Besides, the most enriched cellular
locations are extracellular region and cell surface (Table S7).
The most enriched pathways are complement and coagulation
cascades, and the second enriched pathways are cell adhesion
molecules (CAMs) (Table S8).
Discussion and Conclusion
A reliable prediction capability for proteins that can travel
from circulation to saliva will represent a highly useful tool as it
can provide a candidate list of biomarkers specific to a
particular disease. This will allow targeted searches for
effective biomarkers in saliva using antibody-based techniques,
in comparison with the traditional search strategies by direct
comparisons among proteomic data collected from saliva
samples of multiple patients and healthy controls, which have
proved to be ineffective in searches for biomarkers in blood
[8,35] and urine [36]. Here we demonstrated that it is possible
to develop one such tool, which by no means represents the
possibly most reliable tool for such a prediction. The key
contribution of work is the proof of principle that we can
possibly identify distinguishing features between proteins that
can move to saliva from circulation and proteins that cannot get
into saliva. In addition the identified features can also provide
useful information to the mechanism studies of how proteins
move between blood and saliva. In the future study, we hope
that our method could be used in conjunction with the
technology platforms for saliva diagnostics, and identify the
definitive disease-associated salivary biomarkers.
Table 3. Prediction Proteins used as salivary biomarkers for
the detection breast cancer.
Not included in the training positive dataset
Accession Protein Name Ratio P-value Blood Secretory
Q01469 Epidermal fatty acid-bindingprotein 0.633 0.000257 Yes
P02788 Lactotransferrin 1.583 0.000244 Yes
Included in the training positive dataset
Accession Protein Name Ratio P-value  
P02787 Transferrin 0.578 0.000013 Yes
P25311 Zinc-alpha-2-glycoprotein 1.563 0.000940 Yes
doi: 10.1371/journal.pone.0080211.t003
Materials and Methods
Collecting salivary proteins coming from blood and
generating negative training data
There is no existing dataset about proteins that can move
from circulation to saliva. Proteins that have been found in both
salivary proteome and blood proteome cannot serve this
purpose since some of the salivary proteins may not come from
circulation, instead are secreted from the salivary glands in
response to other biomolecules that get into the glands from
circulation. Therefore, we collected proteins that can move
from circulation to saliva and have been experimentally
validated and reported in the literature, such as IgA [6,37],
albumin and Zn-alpha2-glycoprotein [38]. 62 such proteins are
found from the literature and used as the positive training data,
shown in Table S9. Considering the relatively small size of this
positive training dataset, we added additional proteins from the
same Pfam families of these 62 proteins with sequence
similarities lower than 30% to our training set, assuming that
proteins in the same Pfam family have the same properties in
getting into saliva. To avoid the issue of over-representing any
particular family, we limit to have at most five additional
members per family, specifically the most distant five members
of each of the 62 proteins. This gives rise to a total of 261
proteins, which are used as the positive training data.
Generating the negative training data is a challenge since
our information about which proteins are movable or not is
clearly incomplete at this point. We employed a method similar
to that proposed by Cui et al. [35] by choosing proteins from
the Pfam families not containing any proteins that have been
detected in saliva. For each such family, we choose five
members as the negative training data. In addition, we keep
only those with at least five peptides in the Plasma Proteome
Project (PPP) database [39], the largest human plasma protein
database. As a result, 6,816 proteins are selected as the
negative dataset.
Feature construction
To train a classifier for proteins that are movable from
circulation to saliva, we consider the following features, which
can be grouped into four categories: (i) general sequence
features such as sequence length, amino acid composition and
di-peptide composition; (ii) physicochemical properties such as
hydrophobicity, normalized Van der Waals volume, polarity,
polarizability, charges, solubility, unfoldability and disordered
regions; (iii) domains/motifs such as signal peptides,
transmembrane domains and twin-arginine signal peptides
motif (TAT); and (iv) structural properties such as secondary
structural content and radius of gyration, totaling 34 features,
represented by 1,523 feature elements. The details of these
features are provided in Table S1.
Feature selection and classification
For each protein, we calculated a feature vector of 1,523
dimensions defined above. We first trained a classifier using all
the 1,523 feature values on the training data, and then applied
a two-stage feature-selection procedure to remove those
irrelevant and redundant features. A permutation test and q-
Prediction Human Salivary Proteins from Blood
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value [9] are used to identify and remove the irrelevant
features. 10,000 permutations are generated and used to
calculate the statistical significance on the relevance of
individual feature elements to the prediction accuracy. Then,
we used the approach proposed by Storey and Tibshirani [9] to
calculate the q-value, which is used to control the False
Discovery Rate (FDR) [40], in terms of the p-value obtained
from the permutation test. We used 0.005 as the q-value cutoff
to remove less relevant features, giving rise to 1,087 retained
feature elements. In the second step, an improved feature
selection method (SVM-RFE) that considers dependence
relationships among features [41] is applied to rank these
features. Then we went through an iterative classification and
feature removal procedure to have kept only 55 feature
elements, which give essentially the same classification result
as using the larger feature set.
A SVM-based classifier is trained on the training data using
the 55 feature elements for each protein, and the output is 1 or
-1 representing if the input protein is movable to saliva or not.
The following parameters are used to evaluate the prediction
performance: recall, precision and the area under curve (AUC)
of the recall-precision curve [42], defined as follows:
recall=   TPTP+FN (1)
precision=   TPTP+FP (2)
where TP is the number of true positives, FP refers to the
number of false positives, and FN is the number of false
negatives.
A method for ranking predicted salivary proteins
We have also ranked the predicted salivary proteins using
the manifold ranking algorithm as in our previous work [8]. The
essence of a manifold ranking algorithm [43,44] can be
intuitively explained as follows: the problem is defined on two
datasets, a true sample set and a background set. Our goal is
to rank the individual members of the background set
according to their relevance to the true samples. A weighted
graph is used to represent the combined true and the
background set, with each sample represented as a node of
the graph and each pair of nodes being represented as an
edge with a weight defined as the similarity between the two
nodes in the feature space. Then an evidence propagation
process starts, in which each true sample propagates its
presence to its neighboring nodes to increase their relevance
to the true sample set, where the increased relevance is valued
proportionally to the corresponding edge weight in the graph.
An overall relevance score of each node is summed over all
the scores propagated to it from all the relevant true samples,
by which elements in the background set can be ranked at the
end. For our problem, the true sample set is the same as the
positive training dataset defined in the previous section, and
the background contains all the 20,209 human proteins in
UniProt minus the positive set.
Identification of genes differentially expressed in breast
cancer
The microarray gene expression datasets GSE15852 for 43
paired samples of breast cancer and adjacent normal tissues
are downloaded from the GEO database of NCBI [45]. For
these samples, we applied t test and fold-change to identify
differentially expressed genes in cancer versus control
samples. The expression fold changes of each gene can be
calculated using the following formula:
f ci= 1m∑j=1
m ci j
ni j
(3)
where fci is the ratio of the gene expression value on cancer
sample versus control sample of gene i. cij is the expression
value of gene i of cancer sample in patient j, and nij is the
expression value of gene i of normal sample in patient j. m = 43
is the sample number. The fci value is greater than one for up-
regulated genes and less than one for down-regulated genes.
To identify differentially expressed genes, we choose 1.5 as
the threshold of fold change (1/1.5 for down-regulation). Then
we can obtain the differentially expressed genes between
cancer samples versus control samples.
P-value calculation for comparison of the ranking result
with human saliva biomarkers
We calculated the statistical significance p-value assuming
the underlying distribution for our problem follows a
hypergeometric distribution [46], i.e., the probability of selecting
s tails in n draws without replacement from a finite population
of size N coins each with an equal probability in selecting a
head versus a tail containing exactly S tails, calculated as
follows:
P x=s = C S,s ⋅C N−S,n−sC N,n =
S
s
N−S
n−s
N
n
(4)
Where C(a, b)=a!/[b!(a−b)!], N is the number of human
proteins, n is the number of the selected top proteins, S is the
number of proteins used as salivary biomarkers, and s is the
number of proteins that are among the 47 known salivary
biomarkers and among the top n predicted candidate proteins.
N is 20,209 and S is 47. Table 1 shows the p-values, for
different s and n.
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